US stock markets are on track for a fourth straight week of declines, for the first time since September 2020.
| NASDAQ | S&P 500 | Bitcoin |
|---|---|---|
| 13,352.78 (-1.40%) | 4,326.51 (-0.54%) | 36,471.00 (-0.02%) |
Here are some trending stocks today:
Apple (NASDAQ: AAPL) is the big story today after its earnings report delivered record profit beating expectations. It also believes supply constraints are easing. Revenue over 4% ahead and EPS over 10.5% better than expectations.
Apple could be set to challenge Square (Block Inc (NYSE: SQ)) by transforming iPhones into POS terminals.
Robinhood Markets (NASDAQ: HOOD) missed analyst expectations on much higher expenses while revenue and expense guidance disappointed.
Reopening of economies drove surge in Mastercard (NYSE: MA) and Visa (NYSE: V) purchase volumes with the impact of Omicron expected to be short-lived. Visa beat expectations in its earnings results with quarterly revenue topping $7bn. While Mastercard’s Q4 revenue was $5.2bn.
Atlassian Corp (NASDAQ: TEAM) reduced losses in Q2 and beat expectations on revenues and adjusted earnings. It also it acquired AI-powered virtual agent company Percept.ai for an undisclosed amount. Management highlighted continued cloud momentum.
Skyworks Solutions (NASDAQ: SWKS) is up pre-market.
Biogen (NASDAQ: BGEN) to sell its share in biosimilar JV Samsung Bioepis for at least $2.25bn to Samsung Biologics. Biogen stock is down pre-market.
Synchrony Financial (NYSE: SYF) reported Q4 profit of $813m, it met consensus analyst estimates for EPS. SYF stock is down pre-market.
Mondelez International (NASDAQ: MDLZ) reported good organic growth but EPS missed on cost inflation.
Western Digital (NASDAQ: WDC) is down over 10% in pre-market trading after guidance failed to meet expectations on supply chain issues.
Chevron (NYSE: CVX) reported a $5bn profit amid surging crude and natural gas prices. CVX earnings miss on a series of non-recurring issues. Guidance for 2022 is lower.
Semiconductor company KLA Corp (NASDAQ: KLAC) guided well below on supply constraints.
Stryker (NYSE: SYK) guided below, flagging unfavorable price reductions and FX. SYK stock trading down.